Jerusalem Pharmaceuticals Co. announced unaudited consolidated preliminary financial results for year ended December 31, 2013. For the period, the company's net profit after taxes reached $2,162,958, compared with a net profit after taxes of $195,590 in the audited data for 2012, a net increase of 1,005.9%.